% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INBOOK{Zafar:145422,
author = {Zafar, Saima and Noor, Aneeqa and Zerr, Inga},
title = {{C}hapter 4 - {T}herapies for prion diseases},
volume = {165},
publisher = {Elsevier},
reportid = {DZNE-2020-00765},
pages = {47 - 58},
year = {2019},
comment = {Handbook of Clinical Neurology},
booktitle = {Handbook of Clinical Neurology},
abstract = {Recent advances in understanding of the molecular biology
of prion diseases and improved clinical diagnostic
techniques might allow researchers to think about
therapeutic trials in Creutzfeldt–Jakob disease (CJD)
patients. Some attempts have been made in the past and
various compounds have been tested in single case reports
and patient series. Controlled trials are rare. However, in
the past few years, it has been demonstrated that clinical
trials are feasible. The clinicians might face several
specific problems when evaluating the efficacy of the drug
in CJD, such as rareness of the disease, lack of appropriate
preclinical tests and heterogeneous clinical presentation in
humans. These problems have to be carefully addressed in
future.},
cin = {Ext UMG Zerr / Göttingen Pre 2020 / AG Zerr},
cid = {I:(DE-2719)5000037 / I:(DE-2719)6000014 /
I:(DE-2719)1440011-1},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)7},
url = {https://pub.dzne.de/record/145422},
}